Soluble RAGE further stratifies risk of coronary artery and end-stage kidney disease in high-risk individuals with type 1 diabetes and treatment-resistant hypertension
Krishna Adeshara, Raija Lithovius, Stefan Mutter, Valma Harjutsalo, Markku Lehto, Per-Henrik Groop, Niina Sandholm, the FinnDiane Study Group · 2025
Read Soluble RAGE further stratifies risk of coronary artery and end-stage kidney disease in high-risk individuals with type 1 diabetes and treatment-resistant hypertension by Krishna Adeshara, Raija Lithovius, Stefan Mutter, Valma Harjutsalo, Markku Lehto, Per-Henrik Groop, Niina Sandholm, the FinnDiane Study Group (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12805710.txt.
Description
Krishna Adeshara and co-authors test a blood marker for sorting risk in a hard-to-treat diabetes group, in this 2025 study. The marker is a soluble form of a receptor tied to inflammation and cell stress. Their patients had type 1 diabetes plus blood pressure that resisted treatment, a mix that sharply raises heart and kidney danger.
The data came from the FinnDiane study, with 1,262 adults on blood pressure drugs and 237 in the resistant group. Higher marker levels went with higher odds of resistant pressure. Over a median of twelve years, sixty-two of the resistant patients developed coronary artery disease. Higher marker levels tracked with greater risk of that outcome and of end-stage kidney failure. Much of the signal faded once kidney function was counted, though the trend remained. The authors suggest the marker, read alongside standard kidney tests, can flag the patients in most danger.
Catalog record
| CREATOR | Krishna Adeshara, Raija Lithovius, Stefan Mutter, Valma Harjutsalo, Markku Lehto, Per-Henrik Groop, Niina Sandholm, the FinnDiane Study Group |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |